Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index. Biomol Biomed [Internet]. 2024 Sep. 22 [cited 2025 Oct. 27];25(1):240–248. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11155